These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 16883550

  • 1. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
    Salama NN, Yang Z, Bui T, Ho RJ.
    J Pharm Sci; 2006 Oct; 95(10):2293-308. PubMed ID: 16883550
    [Abstract] [Full Text] [Related]

  • 2. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388
    [Abstract] [Full Text] [Related]

  • 3. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 4. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A, Watanabe H, Maeda Y, Yokoo K, Sanematsu E, Fujii J, Sasaki J, Hamada A, Saito H.
    Biochem Pharmacol; 2008 Feb 15; 75(4):973-80. PubMed ID: 18054347
    [Abstract] [Full Text] [Related]

  • 5. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
    Tang F, Ouyang H, Yang JZ, Borchardt RT.
    J Pharm Sci; 2004 May 15; 93(5):1185-94. PubMed ID: 15067695
    [Abstract] [Full Text] [Related]

  • 6. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep 15; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 7. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
    Crouthamel MH, Wu D, Yang Z, Ho RJ.
    J Pharm Sci; 2006 Dec 15; 95(12):2767-77. PubMed ID: 16917872
    [Abstract] [Full Text] [Related]

  • 8. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S.
    Pharm Res; 2006 Jul 15; 23(7):1460-72. PubMed ID: 16779700
    [Abstract] [Full Text] [Related]

  • 9. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
    Woodahl EL, Crouthamel MH, Bui T, Shen DD, Ho RJ.
    Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):183-8. PubMed ID: 19123050
    [Abstract] [Full Text] [Related]

  • 10. Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function.
    Patanasethanont D, Nagai J, Yumoto R, Murakami T, Sutthanut K, Sripanidkulchai BO, Yenjai C, Takano M.
    J Pharm Sci; 2007 Jan 15; 96(1):223-33. PubMed ID: 17031860
    [Abstract] [Full Text] [Related]

  • 11. MDR1 C2005T polymorphism changes substrate specificity.
    Liu L, Fan L, Peng X, Hu D, Zhou H.
    Cancer Chemother Pharmacol; 2010 Aug 15; 66(3):617-23. PubMed ID: 20309692
    [Abstract] [Full Text] [Related]

  • 12. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
    Iwaki K, Sakaeda T, Kakumoto M, Nakamura T, Komoto C, Okamura N, Nishiguchi K, Shiraki T, Horinouchi M, Okumura K.
    J Pharm Pharmacol; 2006 Dec 15; 58(12):1617-22. PubMed ID: 17331325
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
    Wang JS, Zhu HJ, Markowitz JS, Donovan JL, DeVane CL.
    Psychopharmacology (Berl); 2006 Sep 15; 187(4):415-23. PubMed ID: 16810505
    [Abstract] [Full Text] [Related]

  • 14. MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    AIDS; 2005 Oct 14; 19(15):1617-25. PubMed ID: 16184031
    [Abstract] [Full Text] [Related]

  • 15. Interaction of imatinib mesilate with human P-glycoprotein.
    Hamada A, Miyano H, Watanabe H, Saito H.
    J Pharmacol Exp Ther; 2003 Nov 14; 307(2):824-8. PubMed ID: 12975485
    [Abstract] [Full Text] [Related]

  • 16. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
    Shen XM, Cheng J.
    DNA Cell Biol; 2019 Mar 14; 38(3):250-255. PubMed ID: 30632789
    [Abstract] [Full Text] [Related]

  • 17. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
    Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):148-58. PubMed ID: 17963743
    [Abstract] [Full Text] [Related]

  • 18. Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
    Inoue T, Osada K, Tagawa M, Ogawa Y, Haga T, Sogame Y, Hashizume T, Watanabe T, Taguchi A, Katsumata T, Yabuki M, Yamaguchi N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):156-62. PubMed ID: 22691713
    [Abstract] [Full Text] [Related]

  • 19. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
    Hashiguchi Y, Hamada A, Shinohara T, Tsuchiya K, Jono H, Saito H.
    Biochem Biophys Res Commun; 2013 Sep 20; 439(2):221-7. PubMed ID: 23981805
    [Abstract] [Full Text] [Related]

  • 20. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
    Fu J, Chen Z, Cen J, Ruan C.
    Chin Med J (Engl); 2000 Mar 20; 113(3):228-31. PubMed ID: 11775252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.